Clinical Trial

Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective multicenter observational study to assess molecular drivers of metastatic breast cancer and disease evolution upon therapeutic pressure. The main aim is to develop and validate prognostic, predictive and pathogenic markers in clinically well-characterized population-based material of breast cancer tumors and the corresponding normal tissue.These data will be used to characterize recurrent breast cancer on a molecular level, study tumor evolution, develop biomarkers of response/resistance to targeted therapy in the metastatic setting, enroll patients on targeted treatment clinical studies and to elucidate mechanisms of resistance to therapy.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-11-28; most recent amendment 2025-09-10.
Status change: Not Yet Recruiting → Recruiting 2019-01-31
Trial Details
NCT Number NCT03758976
Lead Sponsor Lund University Hospital
Conditions Metastatic Breast Cancer
Enrollment 2,000 participants
Start Date 2019-01-21
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-16